If you participate in a trial that investigates a new diagnostic test, your medical therapy should not change at all. You can expect to be treated according to current medical standards no matter whether you participate in the study or not. If a new treatment is tested, you possibly receive a drug that may have unknown effects. Usually, study participants are randomly assigned to receive the new drug (“investigational product”) or the currently recommended treatment. It is unknown, which of both therapies is superior.